554 related articles for article (PubMed ID: 25855742)
21. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A
Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918
[TBL] [Abstract][Full Text] [Related]
22. Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry.
Tran EE; Nelson EA; Bonagiri P; Simmons JA; Shoemaker CJ; Schmaljohn CS; Kobinger GP; Zeitlin L; Subramaniam S; White JM
J Virol; 2016 Sep; 90(17):7618-27. PubMed ID: 27279622
[TBL] [Abstract][Full Text] [Related]
23. Single-Nucleotide Polymorphisms in Human NPC1 Influence Filovirus Entry Into Cells.
Kondoh T; Letko M; Munster VJ; Manzoor R; Maruyama J; Furuyama W; Miyamoto H; Shigeno A; Fujikura D; Takadate Y; Yoshida R; Igarashi M; Feldmann H; Marzi A; Takada A
J Infect Dis; 2018 Nov; 218(suppl_5):S397-S402. PubMed ID: 30010949
[TBL] [Abstract][Full Text] [Related]
24. Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity.
Wirchnianski AS; Wec AZ; Nyakatura EK; Herbert AS; Slough MM; Kuehne AI; Mittler E; Jangra RK; Teruya J; Dye JM; Lai JR; Chandran K
Front Immunol; 2021; 12():729851. PubMed ID: 34721393
[TBL] [Abstract][Full Text] [Related]
25. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step.
Mingo RM; Simmons JA; Shoemaker CJ; Nelson EA; Schornberg KL; D'Souza RS; Casanova JE; White JM
J Virol; 2015 Mar; 89(5):2931-43. PubMed ID: 25552710
[TBL] [Abstract][Full Text] [Related]
26. Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats.
Ng M; Ndungo E; Kaczmarek ME; Herbert AS; Binger T; Kuehne AI; Jangra RK; Hawkins JA; Gifford RJ; Biswas R; Demogines A; James RM; Yu M; Brummelkamp TR; Drosten C; Wang LF; Kuhn JH; Müller MA; Dye JM; Sawyer SL; Chandran K
Elife; 2015 Dec; 4():. PubMed ID: 26698106
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry Factors.
Zapatero-Belinchón FJ; Dietzel E; Dolnik O; Döhner K; Costa R; Hertel B; Veselkova B; Kirui J; Klintworth A; Manns MP; Pöhlmann S; Pietschmann T; Krey T; Ciesek S; Gerold G; Sodeik B; Becker S; von Hahn T
Viruses; 2019 Mar; 11(3):. PubMed ID: 30893855
[TBL] [Abstract][Full Text] [Related]
28. Novel Small Molecule Entry Inhibitors of Ebola Virus.
Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
[TBL] [Abstract][Full Text] [Related]
30. Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses.
Wang LL; Estrada L; Wiggins J; Anantpadma M; Patten JJ; Davey RA; Xiang SH
Antiviral Res; 2022 Oct; 206():105399. PubMed ID: 36007601
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.
Lennemann NJ; Rhein BA; Ndungo E; Chandran K; Qiu X; Maury W
mBio; 2014 Jan; 5(1):e00862-13. PubMed ID: 24473128
[TBL] [Abstract][Full Text] [Related]
32. A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.
Martinez O; Ndungo E; Tantral L; Miller EH; Leung LW; Chandran K; Basler CF
J Virol; 2013 Mar; 87(6):3324-34. PubMed ID: 23302883
[TBL] [Abstract][Full Text] [Related]
33. Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1.
Ng M; Ndungo E; Jangra RK; Cai Y; Postnikova E; Radoshitzky SR; Dye JM; Ramírez de Arellano E; Negredo A; Palacios G; Kuhn JH; Chandran K
Virology; 2014 Nov; 468-470():637-646. PubMed ID: 25310500
[TBL] [Abstract][Full Text] [Related]
34. Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor.
Krishnan A; Miller EH; Herbert AS; Ng M; Ndungo E; Whelan SP; Dye JM; Chandran K
Viruses; 2012 Oct; 4(11):2471-84. PubMed ID: 23202491
[TBL] [Abstract][Full Text] [Related]
35. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
[TBL] [Abstract][Full Text] [Related]
36. Cell-cell contact promotes Ebola virus GP-mediated infection.
Miao C; Li M; Zheng YM; Cohen FS; Liu SL
Virology; 2016 Jan; 488():202-15. PubMed ID: 26655238
[TBL] [Abstract][Full Text] [Related]
37. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.
Yonezawa A; Cavrois M; Greene WC
J Virol; 2005 Jan; 79(2):918-26. PubMed ID: 15613320
[TBL] [Abstract][Full Text] [Related]
38. Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies.
Ilinykh PA; Shen X; Flyak AI; Kuzmina N; Ksiazek TG; Crowe JE; Bukreyev A
J Virol; 2016 Apr; 90(8):3890-3901. PubMed ID: 26819310
[TBL] [Abstract][Full Text] [Related]
39. Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry.
Qiu S; Leung A; Bo Y; Kozak RA; Anand SP; Warkentin C; Salambanga FDR; Cui J; Kobinger G; Kobasa D; Côté M
Virology; 2018 Jan; 513():17-28. PubMed ID: 29031163
[TBL] [Abstract][Full Text] [Related]
40. Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1.
Khan I; Li S; Tao L; Wang C; Ye B; Li H; Liu X; Ahmad I; Su W; Zhong G; Wen Z; Wang J; Hua RH; Ma A; Liang J; Wan XP; Bu ZG; Zheng YH
Nat Commun; 2024 Jan; 15(1):162. PubMed ID: 38167417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
